Annual Accounts Payable
$4.63 M
+$2.56 M+123.12%
December 31, 2023
Summary
- As of March 13, 2025, NRXPW annual accounts payable is $4.63 million, with the most recent change of +$2.56 million (+123.12%) on December 31, 2023.
- During the last 3 years, NRXPW annual accounts payable has risen by +$1.48 million (+46.91%).
- NRXPW annual accounts payable is now at all-time high.
Performance
NRXPW Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.87 M
-$149.00 K-2.97%
September 30, 2024
Summary
- As of March 13, 2025, NRXPW quarterly accounts payable is $4.87 million, with the most recent change of -$149.00 thousand (-2.97%) on September 30, 2024.
- Over the past year, NRXPW quarterly accounts payable has stayed the same.
- NRXPW quarterly accounts payable is now -22.37% below its all-time high of $6.27 million, reached on June 30, 2021.
Performance
NRXPW Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NRXPW Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.1% | 0.0% |
| 3 y3 years | +46.9% | +58.1% |
| 5 y5 years | +644.2% | +58.1% |
NRXPW Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.1% | -22.3% | +58.1% |
| 5 y | 5-year | at high | +644.2% | -22.4% | >+9999.0% |
| alltime | all time | at high | +644.2% | -22.4% | >+9999.0% |
NRx Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.87 M(-3.0%) |
| Jun 2024 | - | $5.01 M(-20.0%) |
| Mar 2024 | - | $6.26 M(+35.3%) |
| Dec 2023 | $4.63 M(+123.1%) | $4.63 M(+27.6%) |
| Sep 2023 | - | $3.63 M(+18.0%) |
| Dec 2022 | $2.08 M(-43.7%) | - |
| Jun 2022 | - | $3.08 M(-28.6%) |
| Mar 2022 | - | $4.31 M(+16.9%) |
| Dec 2021 | $3.69 M | $3.69 M(-33.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $5.56 M(-11.3%) |
| Jun 2021 | - | $6.27 M(>+9900.0%) |
| Dec 2020 | $3.15 M(+406.6%) | $609.51(>+9900.0%) |
| Sep 2020 | - | $0.38(-100.0%) |
| Jun 2020 | - | $297.24 K(-5.1%) |
| Mar 2020 | - | $313.24 K(-49.7%) |
| Dec 2019 | $622.44 K | $622.44 K(+15.8%) |
| Sep 2019 | - | $537.31 K(+24.2%) |
| Jun 2019 | - | $432.45 K(-3.1%) |
| Mar 2019 | - | $446.37 K |
FAQ
- What is NRx Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual accounts payable year-on-year change?
- What is NRx Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
What is NRx Pharmaceuticals annual accounts payable?
The current annual accounts payable of NRXPW is $4.63 M
What is the all time high annual accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual accounts payable is $4.63 M
What is NRx Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, NRXPW annual accounts payable has changed by +$2.56 M (+123.12%)
What is NRx Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of NRXPW is $4.87 M
What is the all time high quarterly accounts payable for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly accounts payable is $6.27 M
What is NRx Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, NRXPW quarterly accounts payable has changed by $0.00 (0.00%)